OpenLegislation

Commission Regulation (EU) No 605/2014 of 5 June 2014 amending, for the purposes of introducing hazard and precautionary statements in the Croatian language and its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance)

EU Regulation No 605/2014 · Adopted 5 June 2014 · Extends to United Kingdom

Original text. legislation.gov.uk does not revise this item, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Commission Regulation (EU) No 605/2014

of 5 June 2014

amending, for the purposes of introducing hazard and precautionary statements in the Croatian language and its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to the Act concerning the conditions of accession of the Republic of Croatia and the adjustments to the Treaty on European Union and the Treaty establishing the European Atomic Energy Communityf1, and in particular Article 50 thereof,

Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006f2, and in particular Article 37(5) thereof,

Whereas:

(1)

Commission Regulation (EU) No 487/2013f3 amends some of the language tables for hazard statements included in Annex III to Regulation (EC) No 1272/2008 and some of the language tables for precautionary statements included in Annex IV to that Regulation. With the accession of Croatia to the European Union on 1 July 2013, it is necessary that all hazard and precautionary statements provided for by Regulation (EC) No 1272/2008 as amended by Commission Regulation (EU) No 487/2013 are available in the Croatian language as well. This Regulation introduces the necessary adjustments to the language tables.

(2)

Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EECf4.

(3)

Proposals for new or updated harmonised classification and labelling of certain substances have been submitted to the European Chemicals Agency (ECHA) pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on the opinions on those proposals issued by the Committee for Risk Assessment of ECHA, as well as on the comments received from the parties concerned, it is appropriate to introduce, remove or update harmonised classification and labelling of certain substances by amending Annex VI to that Regulation.

(4)

Compliance with the new harmonised classifications should not be required immediately, as a certain period of time will be necessary to allow suppliers to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow suppliers to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Councilf5.

(5)

In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the new harmonised classifications and of adapting the labelling and packaging accordingly on a voluntary basis before the deadline for compliance.

(6)

The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,

HAS ADOPTED THIS REGULATION:

Annotations to the whole text

Footnotes

f1

OJ L 112, 24.4.2012, p. 21.

f2

OJ L 353, 31.12.2008, p. 1.

f3

Commission Regulation (EU) No 487/2013 of 8 May 2013 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and the Council on classification, labelling and packaging of substances and mixtures (OJ L 149, 1.6.2013, p. 1).

f4

Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (OJ L 196, 16.8.1967, p. 1).

f5

Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).

Contents

  1. 1Article 1
  2. 2Article 2
  3. 3Article 3
  4. Signature
  5. Annex IAnnex I
  6. Annex IIAnnex II
  7. Annex IIIAnnex III

1

Regulation (EC) No 1272/2008 is amended as follows:

  1. (1)

    Annex III is amended in accordance with Annex I to this Regulation;

  2. (2)

    Annex IV is amended in accordance with Annex II to this Regulation;

  3. (3)

    Annex VI is amended in accordance with Annex III to this Regulation.

2

1.

By way of derogation from Article 3(2), substances and mixtures may, before 1 December 2014 and 1 June 2015 respectively, be classified, labelled and packaged in accordance with this Regulation.

2.

By way of derogation from Article 3(2), substances classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 and placed on the market before 1 December 2014, shall not be required to be relabelled and repackaged in accordance with this Regulation until 1 December 2016.

3.

By way of derogation from Article 3(2), mixtures classified, labelled and packaged in accordance with Directive 1999/45/EC of the European Parliament and of the Councilf1 or Regulation (EC) No 1272/2008 and placed on the market before 1 June 2015, shall not be required to be relabelled and repackaged in accordance with this Regulation until 1 June 2017.

4.

By way of derogation from Article 3(3), the harmonised classifications set out in Annex III to this Regulation may be applied before the date referred to in Article 3(3).

3

1.

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

2.

Article 1(1) and (2) shall apply in respect of substances from 1 December 2014 and in respect of mixtures from 1 June 2015.

F13.

Article 1(3) shall apply from 1 January 2016 .

Signature

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Annex I

In Part 1 of Annex III, Table 1.1 is amended as follows:

  1. (1)

    in code H229, the following is inserted after the entry corresponding to GA:

    ‘

    HRSpremnik pod tlakom: može se rasprsnuti ako se grije.

    ’

  2. (2)

    in code H230, the following is inserted after the entry corresponding to GA:

    ‘

    HRMože eksplozivno reagirati i bez prisustva zraka.

    ’

  3. (3)

    in code H231, the following is inserted after the entry corresponding to GA:

    ‘

    HRMože eksplozivno reagirati i bez prisustva zraka na povišenom tlaku i/ili temperaturi.

    ’

Annex II

Part 2 to Annex IV is amended as follows:

  1. (1)

    Table 1.2 is amended as follows:

    1. (a)

      in code P210, the following is inserted after the entry corresponding to GA:

      ‘

      HRČuvati odvojeno od topline, vrućih površina, iskri, otvorenih plamena i ostalih izvora paljenja. Ne pušiti.

      ’

    2. (b)

      in code P223: The following is inserted after the entry corresponding to GA:

      ‘

      HRSpriječiti dodir s vodom.

      ’

    3. (c)

      in code P244, the following is inserted after the entry corresponding to GA:

      ‘

      HRSpriječiti dodir ventila i spojnica s uljem i masti.

      ’

    4. (d)

      in code P251, the following is inserted after the entry corresponding to GA:

      ‘

      HRNe bušiti, niti paliti čak niti nakon uporabe.

      ’

    5. (e)

      in code P284, the following is inserted after the entry corresponding to GA:

      ‘

      HR[U slučaju nedovoljne ventilacije] nositi sredstva za zaštitu dišnog sustava.

      ’

  2. (2)

    Table 1.3 is amended as follows:

    1. (a)

      in code P310, the following is inserted after the entry corresponding to GA:

      ‘

      HROdmah nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…

      ’

    2. (b)

      in code P 311, the following is inserted after the entry corresponding to GA:

      ‘

      HRNazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…

      ’

    3. (c)

      in code P312: The following is inserted after the entry corresponding to GA:

      ‘

      HRU slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…

      ’

    4. (d)

      in code P340, the following is inserted after the entry corresponding to GA:

      ‘

      HRPremjestiti osobu na svježi zrak i postaviti ju u položaj koji olakšava disanje.

      ’

    5. (e)

      in code P352, the following is inserted after the entry corresponding to GA:

      ‘

      HROprati velikom količinom vode/…

      ’

    6. (f)

      in code P361, the following is inserted after the entry corresponding to GA:

      ‘

      HROdmah skinuti svu zagađenu odjeću.

      ’

    7. (g)

      in code P362, the following is inserted after the entry corresponding to GA:

      ‘

      HRSkinuti zagađenu odjeću.

      ’

    8. (h)

      in code P364, the following is inserted after the entry corresponding to GA:

      ‘

      HRI oprati je prije ponovne uporabe.

      ’

    9. (i)

      in code P378, the following is inserted after the entry GA:

      ‘

      HRZa gašenje rabiti …

      ’

    10. (j)

      in combined codes P301 + P310, the following is inserted after the entry corresponding to GA:

      ‘

      HRAKO SE PROGUTA: odmah nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…

      ’

    11. (k)

      in combined codes P301 + P312, the following is inserted after the entry corresponding to GA:

      ‘

      HRAKO SE PROGUTA: u slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…

      ’

    12. (l)

      in combined codes P302 + P352, the following is inserted after the entry corresponding to GA:

      ‘

      HRU SLUČAJU DODIRA S KOŽOM: oprati velikom količinom vode/…

      ’

    13. (m)

      in combined codes P303 + P361+P353, the following is inserted after the entry corresponding to GA:

      ‘

      HRU SLUČAJU DODIRA S KOŽOM (ili kosom): odmah skinuti svu zagađenu odjeću. Isprati kožu vodom/tuširanjem.

      ’

    14. (n)

      in combined codes P304 + P340, the following is inserted after the entry corresponding to GA:

      ‘

      HRAKO SE UDIŠE: premjestiti osobu na svježi zrak i postaviti ju u položaj koji olakšava disanje.

      ’

    15. (o)

      in combined codes P308 + P311, the following is inserted after the entry corresponding to GA:

      ‘

      HRU SLUČAJU izloženosti ili sumnje na izloženost: nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…

      ’

    16. (p)

      in combined codes P342 + P311, the following is inserted after the entry corresponding to GA:

      ‘

      HRPri otežanom disanju: nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…

      ’

    17. (q)

      in combined codes P361 + P364, the following is inserted after the entry corresponding to GA:

      ‘

      HROdmah skinuti svu zagađenu odjeću i oprati je prije ponovne uporabe.

      ’

    18. (r)

      in combined codes P362 + P364, the following is inserted after the entry corresponding to GA:

      ‘

      HRSkinuti zagađenu odjeću i oprati je prije ponovne uporabe.

      ’

    19. (s)

      in combined codes P370 + P378, the following is inserted after the entry corresponding to GA:

      ‘

      HRU slučaju požara: za gašenje rabiti …

      ’

Annex III

Part 3 of Annex VI is amended as follows:

  1. (1)

    Table 3.1 is amended as follows:

    1. (a)

      the entry corresponding to index number 015-188-00-X is deleted;

    2. (b)

      the entries corresponding to index numbers 006-086-00-6, 015-154-00-4, 015-192-00-1, 601-023-00-4, 601-026-00-0, 603-061-00-7, 605-001-00-5, 605-008-00-3 and 616-035-00-5 are replaced by the following corresponding entries:

      ‘

      006-086-00-6fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate276-696-772490-01-8

      Carc. 2

      Aquatic Acute 1

      Aquatic Chronic 1

      H351

      H400

      H410

      GHS08

      GHS09

      Wng

      H351

      H410

      M = 1

      M = 10 000

      015-154-00-4ethephon; 2-chloroethylphosphonic acid240-718-316672-87-0

      Acute Tox. 3

      Acute Tox. 4

      Acute Tox. 4

      Skin Corr. 1C

      Aquatic Chronic 2

      H311

      H332

      H302

      H314

      H411

      GHS06

      GHS05

      GHS09

      Dgr

      H311

      H332

      H302

      H314

      H411

      		EUH071
      015-192-00-1tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate432-770-2139189-30-3Skin Sens. 1H317

      GHS07

      Wng

      		H317
      601-023-00-4ethylbenzene202-849-4100-41-4

      Flam. Liq. 2

      Acute Tox. 4*

      STOT RE 2

      Asp. Tox. 1

      H225

      H332

      H373 (hearing organs)

      H304

      GHS02

      GHS07

      GHS08

      Dgr

      H225

      H332

      H373 (hearing organs)

      H304

      601-026-00-0styrene202-851-5100-42-5

      Flam. Liq. 3

      Repr. 2

      Acute Tox. 4*

      STOT RE 1

      Skin Irrit. 2

      Eye Irrit. 2

      H226

      H361d

      H332

      H372 (hearing organs)

      H315

      H319

      GHS02

      GHS08

      GHS07

      Dgr

      H226

      H361d

      H332

      H372 (hearing organs)

      H315

      H319

      		*D
      603-061-00-7

      tetrahydro-2-furylmethanol;

      tetrahydrofurfuryl alcohol

      		202-625-697-99-4

      Repr. 1B

      Eye Irrit. 2

      H360Df

      H319

      GHS08

      GHS07

      Dgr

      H360Df

      H319

      605-001-00-5formaldehyde …%200-001-850-00-0

      Carc. 1B

      Muta. 2

      Acute Tox. 3*

      Acute Tox. 3*

      Acute Tox. 3*

      Skin Corr. 1B

      Skin Sens. 1

      H350

      H341

      H301

      H311

      H331

      H314

      H317

      GHS08

      GHS06

      GHS05

      Dgr

      H350

      H341

      H301

      H311

      H331

      H314

      H317

      *

      Skin Corr. 1B; H314: C ≥ 25 %

      Skin Irrit. 2; H315: 5 % ≤ C < 25 %

      Eye Irrit. 2; H319: 5 % ≤ C < 25 %

      STOT SE 3; H335: C ≥ 5 %

      Skin Sens. 1; H317: C ≥ 0,2 %

      		B, D
      605-008-00-3

      acrolein;

      prop-2-enal;

      acrylaldehyde

      		203-453-4107-02-8

      Flam. Liq. 2

      Acute Tox. 1

      Acute Tox. 2

      Acute Tox. 3

      Skin Corr. 1B

      Aquatic Acute 1

      Aquatic Chronic 1

      H225

      H330

      H300

      H311

      H314

      H400

      H410

      GHS02

      GHS06

      GHS05

      GHS09

      Dgr

      H225

      H330

      H300

      H311

      H314

      H410

      		EUH071

      Skin Corr. 1B;

      H314: C ≥ 0,1 %

      M = 100

      M = 1

      		D
      616-035-00-5

      cymoxanil (ISO);

      2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide

      		261-043-057966-95-7

      Repr. 2

      Acute Tox. 4

      STOT RE 2

      Skin Sens. 1

      Aquatic Acute 1

      Aquatic Chronic 1

      H361fd

      H302

      H373 (blood, thymus)

      H317

      H400

      H410

      GHS08

      GHS07

      GHS09

      Wng

      H361fd

      H302

      H373 (blood, thymus)

      H317

      H410

      M = 1

      M = 1

      ’

    3. (c)

      the following entries are inserted in accordance with the order of the entries set out in Table 3.1:

      ‘

      050-028-00-22-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate260-829-057583-35-4

      Repr. 2

      Acute Tox. 4

      STOT RE 1

      Skin Sens. 1A

      H361d

      H302

      H372 (nervous system, immune system)

      H317

      GHS08

      GHS07

      Dgr

      H361d

      H302

      H372 (nervous system, immune system)

      H317

      050-029-00-8dimethyltin dichloride212-039-2753-73-1

      Repr. 2

      Acute Tox. 2

      Acute Tox. 3

      Acute Tox. 3

      STOT RE 1

      Skin Corr. 1B

      H361d

      H330

      H301

      H311

      H372 (nervous system, immune system)

      H314

      GHS08

      GHS06

      GHS05

      Dgr

      H361d

      H330

      H301

      H311

      H372 (nervous system, immune system)

      H314

      		EUH071
      601-088-00-94-vinylcyclohexene202-848-9100-40-3Carc. 2H351

      GHS08

      Wng

      		H351
      601-089-00-4muscalure; cis-tricos-9-ene248-505-727519-02-4Skin Sens. 1BH317

      GHS07

      Wng

      		H317
      604-090-00-84-tert-butylphenol202-679-098-54-4

      Repr. 2

      Skin Irrit. 2

      Eye Dam. 1

      H361f

      H315

      H318

      GHS08

      GHS05

      Dgr

      H361f

      H315

      H318

      604-091-00-3etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether407-980-280844-07-1

      Lact.

      Aquatic Acute 1

      Aquatic Chronic 1

      H362

      H400

      H410

      GHS09

      Wng

      H362

      H410

      M = 100

      M = 1 000

      606-146-00-7tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one-87820-88-0

      Carc. 2

      Acute Tox. 4

      Aquatic Chronic 2

      H351

      H302

      H411

      GHS08

      GHS07

      GHS09

      Wng

      H351

      H302

      H411

      606-147-00-2cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one405-230-9101205-02-1Repr. 2H361d

      GHS08

      Wng

      		H361d
      607-705-00-8benzoic acid200-618-265-85-0

      STOT RE 1

      Skin Irrit. 2

      Eye Dam. 1

      H372 (lungs) (inhalation)

      H315

      H318

      GHS08

      GHS05

      Dgr

      H372 (lungs) (inhalation)

      H315

      H318

      607-706-00-3methyl 2,5-dichlorobenzoate220-815-72905-69-3

      Acute Tox. 4

      STOT SE 3

      Aquatic Chronic 2

      H302

      H336

      H411

      GHS07

      GHS09

      Wng

      H302

      H336

      H411

      612-287-00-5fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine-79622-59-6

      Repr. 2

      Acute Tox. 4

      Eye Dam. 1

      Skin Sens. 1A

      Aquatic Acute 1

      Aquatic Chronic 1

      H361d

      H332

      H318

      H317

      H400

      H410

      GHS08

      GHS07

      GHS05

      GHS09

      Dgr

      H361d

      H332

      H318

      H317

      H410

      M = 10

      M = 10

      613-317-00-Xpenconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole266-275-666246-88-6

      Repr. 2

      Acute Tox. 4

      Aquatic Acute 1

      Aquatic Chronic 1

      H361d

      H302

      H400

      H410

      GHS08

      GHS07

      GHS09

      Wng

      H361d

      H302

      H410

      M = 1

      M = 1

      613-318-00-5fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate-473798-59-3Aquatic Chronic 2H411GHS09H411
      616-212-00-73-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate259-627-555406-53-6

      Acute Tox. 3

      Acute Tox. 4

      STOT RE 1

      Eye Dam. 1

      Skin Sens. 1

      Aquatic Acute 1

      Aquatic Chronic 1

      H331

      H302

      H372 (larynx)

      H318

      H317

      H400

      H410

      GHS06

      GHS08

      GHS05

      GHS09

      Dgr

      H331

      H302

      H372 (larynx)

      H318

      H317

      H410

      M = 10

      M = 1

      ’

  2. (2)

    Table 3.2 is amended as follows:

    1. (a)

      the entry corresponding to index number 015-188-00-X is deleted;

    2. (b)

      the entries corresponding to index numbers 006-086-00-6, 015-154-00-4, 015-192-00-1, 601-023-00-4, 601-026-00-0, 603-061-00-7, 605-001-00-5 and 616-035-00-5 are replaced by the following corresponding entries:

      ‘

      006-086-00-6fenoxycarb (ISO);ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate276-696-772490-01-8

      Carc. Cat. 3; R40

      N; R50-53

      Xn; N

      R: 40-50/53

      S: (2-)22-36/37-60-61

      N; R50-53: C ≥ 25 %

      N; R51-53: 2,5 % ≤ C < 25 %

      R52-53: 0,25 % ≤ C < 2,5 %

      015-154-00-4ethephon; 2-chloroethylphosphonic acid240-718-316672-87-0

      C; R34

      Xn; R20/21/22

      N; R51-53

      C; N

      R: 20/21/22-34-51/53

      S: (1/2-)26-36/37/39-45-61

      		Xi; R37: 5 % ≤ C < 10 %
      015-192-00-1tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate432-770-2139189-30-3R43

      Xi

      R: 43

      S: (2-)24-37

      601-023-00-4ethylbenzene202-849-4100-41-4

      F; R11

      Xn; R20-48/20-65

      F; Xn

      R: 11-20-48/20-65

      S: (2-)16-24/25-29-62

      601-026-00-0styrene202-851-5100-42-5

      Repr. Cat. 3; R63

      Xn; R20-48/20

      Xi; R36/38

      R10

      Xn

      R: 10-20-36/38-48/20-63

      S: (2-)23-36/37-46

      Xn; R20: C ≥ 12,5 %

      Xi; R36/38: C ≥ 12,5 %

      		D
      603-061-00-7

      tetrahydro-2-furylmethanol;

      tetrahydrofurfuryl alcohol

      		202-625-697-99-4

      Repr. Cat. 2; R61

      Repr. Cat. 3; R62

      Xi; R36

      T

      R: 36-61-62

      S: 45-53

      		Xi; R36: C ≥ 10 %
      605-001-00-5formaldehyde …%200-001-850-00-0

      Carc. Cat. 2; R45

      Muta. Cat. 3; R68

      T; R23/24/25

      C; R34

      R43

      T

      R: 23/24/25-34-43-45-68

      S: 45-53

      T; R23/24/25: C ≥ 25 %

      Xn; R20/21/22: 5 % ≤ C < 25 %

      C; R34: C ≥ 25 %

      Xi; R36/37/38: 5 % ≤ C < 25 %

      R43: C ≥ 0,2 %

      		B, D
      616-035-00-5

      cymoxanil (ISO);

      2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide

      		261-043-057966-95-7

      Repr. Cat. 3; R62-63

      Xn; R22-48/22

      R43

      N; R50-53

      Xn; N

      R: 22-43-48/22-62-63-50/53

      S: (2-)36/37-46-60-61

      N; R50-53: C ≥ 25 %

      N; R51-53: 2,5 % ≤ C < 25 %

      R52-53: 0,25 % ≤ C < 2,5 %

      ’

    3. (c)

      the following entries are inserted in accordance with the order of the entries set out in Table 3.2:

      ‘

      050-028-00-22-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate260-829-057583-35-4

      Repr. Cat. 3; R63

      T; R48/25

      Xn; R22

      R43

      T

      R: 22-43-48/25-63

      S: (1/2-)36/37-45

      050-029-00-8dimethyltin dichloride212-039-2753-73-1

      Repr. Cat. 3; R63

      T+; R26

      T; R24/25-48/25

      C; R34

      T+

      R: 24/25-26-34-48/25-63

      S: (1/2-)26-28-36/37/39-45-63

      601-088-00-94-vinylcyclohexene202-848-9100-40-3Carc. Cat. 3; R40

      Xn

      R: 40

      S: (2-)36/37

      601-089-00-4muscalure; cis-tricos-9-ene248-505-727519-02-4R43

      Xi

      R: 43

      S: (2-)24-37

      604-090-00-84-tert-butylphenol202-679-098-54-4

      Repr. Cat. 3; R62

      Xi; R38-41

      Xn

      R: 38-41-62

      S: (2-)26-36/37/39-46

      604-091-00-3etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether407-980-280844-07-1

      R64

      N; R50-53

      N

      R: 50/53-64

      S: 60-61

      N; R50-53: C ≥ 0,25 %

      N; R51-53: 0,025 % ≤ C < 0,25 %

      R52-53: 0,0025 % ≤ C < 0,025 %

      606-146-00-7tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one–87820-88-0

      Carc. Cat. 3; R40

      Xn; R22

      N; R51-53

      Xn; N

      R: 22-40-51/53

      S: (2-)36/37-60-61

      606-147-00-2cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one405-230-9101205-02-1

      F; R11

      Repr. Cat. 3; R63

      F; Xn

      R: 11-63

      S: (2-)16-36/37-46

      607-705-00-8benzoic acid200-618-265-85-0

      T; R48/23

      Xi; R38-41

      T

      R: 38-41-48/23

      S: (1/2-)26-39-45-63

      607-706-00-3methyl 2,5-dichlorobenzoate220-815-72905-69-3

      Xn; R22

      N; R51-53

      Xn; N

      R: 22-51/53

      S: (2-) 46-61

      612-287-00-5fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine-79622-59-6

      Repr. Cat. 3; R63

      Xn; R20

      Xi; R41

      R43

      N; R50-53

      Xn; N

      R: 20-41-43-50/53-63

      S: (2-)26-36/37/39-46-60-61

      N; R50-53: C ≥ 2,5 %

      N; R51-53: 0,25 % ≤ C < 2,5 %

      R52-53: 0,025 % ≤ C < 0,25 %

      613-317-00-Xpenconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole266-275-666246-88-6

      Repr. Cat. 3; R63

      Xn; R22

      N; R50-53

      Xn; N

      R: 22-50/53-63

      S: (2-) 36/37-46-60-61

      N; R50-53: C ≥ 25 %

      N; R51-53: 2,5 % ≤ C < 25 %

      R52-53: 0,25 % ≤ C < 2,5 %

      613-318-00-5fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate-473798-59-3N; R51-53

      N

      R: 51/53

      S: 60-61

      616-212-00-73-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate259-627-555406-53-6

      T; R23-48/23

      Xn; R22

      Xi; R41

      R43

      N; R50

      T; N

      R: 22-23-41-43-48/23-50

      S: (1/2-)24-26-37/39-45-63

      		N; R50: C ≥ 2,5 %

      ’